A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
Status:
Completed
Trial end date:
2017-05-30
Target enrollment:
Participant gender:
Summary
An open-label, randomized, single-dose, 2X3X3 partial replicate, crossover study to compare
the pharmacokinetics and safety between a fixed dose combination of
Fimasartan/Amlodipine/Rosuvastatin and Co-administration of a fixed dose combination of
Fimasartan/Amlodipine and Rosuvastatin in healthy male subjects.